Syros Pharmaceuticals Inc... (SYRS)
0.08
-0.06 (-44.13%)
At close: Mar 03, 2025, 3:59 PM
0.08
-5.64%
Pre-market: Mar 04, 2025, 08:18 AM EST
Syros Pharmaceuticals Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 139.53M | 167.47M | 92.3M | 173.98M | 41.44M | 49.89M | 32.2M | 58.59M | 35.91M | 60.39M | 3.8M |
| Short-Term Investments | n/a | 34.84M | 38.07M | n/a | 49.98M | 49.79M | 39.84M | 25M | n/a | n/a | n/a |
| Long-Term Investments | n/a | 3.09M | 13.04M | 3.09M | 3.09M | 290K | 290K | 483K | 483K | n/a | n/a |
| Other Long-Term Assets | 3.71M | 5.35M | 6.03M | 1.97M | 490K | 881K | 1.1M | 482K | 1.9M | 70K | 70K |
| Receivables | n/a | 1.69M | 2.98M | 2.33M | 20.16M | n/a | n/a | 867K | n/a | n/a | n/a |
| Inventory | n/a | 1.00 | n/a | 1.00 | 290K | n/a | n/a | 1.00 | n/a | n/a | n/a |
| Other Current Assets | 5.45M | 7.39M | 3.24M | 2.24M | 2.94M | 2.06M | 1.11M | 2.1M | 540K | 150K | 112K |
| Total Current Assets | 144.98M | 211.39M | 136.59M | 178.56M | 114.51M | 101.73M | 73.16M | 85.51M | 36.45M | 60.54M | 3.91M |
| Property-Plant & Equipment | 19.48M | 24.66M | 27.29M | 29.64M | 31.89M | 3.86M | 3.94M | 4.85M | 4.8M | 881K | 938K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 23.19M | 33.09M | 46.35M | 34.69M | 35.47M | 5.03M | 5.33M | 5.82M | 7.18M | 951K | 1.01M |
| Total Assets | 168.17M | 244.49M | 182.94M | 213.25M | 149.98M | 106.77M | 78.49M | 91.32M | 43.63M | 61.49M | 4.92M |
| Account Payables | 11.54M | 6.41M | 3.69M | 3.6M | 5.85M | 3.31M | 2.28M | 2.42M | 5.04M | 928K | 594K |
| Deferred Revenue | n/a | 4.33M | 10.18M | 12.21M | 5.74M | 1.93M | 355K | 550K | n/a | n/a | n/a |
| Short-Term Debt | 8.99M | 4.14M | 4.02M | 3.46M | 2.56M | 18K | 94K | 336K | 133K | n/a | n/a |
| Other Current Liabilities | 16.15M | 15.89M | 13.61M | 9.36M | 9.37M | 14.28M | 10.04M | 6.27M | 2.79M | 324K | 316K |
| Total Current Liabilities | 36.68M | 30.78M | 31.51M | 28.62M | 23.52M | 19.53M | 12.41M | 9.57M | 7.96M | 1.25M | 910K |
| Long-Term Debt | 53.08M | 61.5M | 63.18M | 64.48M | 24.64M | 22K | 6K | 53K | 206K | n/a | n/a |
| Other Long-Term Liabilities | 61.75M | 24.47M | 3.03M | 19.71M | n/a | 353K | 745K | 1.1M | 1.42M | 1K | n/a |
| Total Long-Term Liabilities | 114.83M | 85.97M | 66.21M | 94.07M | 47.28M | 8.65M | 751K | 1.15M | 1.63M | 1K | n/a |
| Total Liabilities | 151.51M | 116.75M | 97.72M | 122.7M | 70.79M | 28.18M | 13.16M | 10.72M | 9.58M | 1.25M | 910K |
| Total Debt | 62.08M | 63.57M | 65.19M | 66.21M | 25.92M | 31K | 53K | 221K | 339K | n/a | n/a |
| Common Stock | 26K | 20K | 61K | 56K | 43K | 34K | 26K | 23K | 2K | 1K | 5K |
| Retained Earnings | -722.81M | -558.23M | -463.58M | -377.02M | -292.98M | -217.54M | -155.27M | -101.26M | -53.51M | -23.7M | -10.26M |
| Comprehensive Income | n/a | 102K | -79K | 0.00 | 24K | -3K | -42K | -9K | -931K | -428K | n/a |
| Shareholders Equity | 16.66M | 127.74M | 85.22M | 90.55M | 79.18M | 78.59M | 65.32M | 80.6M | 34.05M | 60.24M | 3.97M |
| Total Investments | 2.12M | 34.84M | 51.1M | 3.09M | 49.98M | 49.79M | 39.84M | 25M | 483K | n/a | n/a |